DENVER and MINNEAPOLIS, Oct. 06, 2025 (GLOBE NEWSWIRE) – OneMedNet Corporation (Nasdaq: ONMD) has partnered with Palantir Technologies (Nasdaq: PLTR) to revolutionize the healthcare AI and Real-World Data (RWD) analytics landscape. Leveraging Palantir’s Artificial Intelligence Platform, OneMedNet will power its iRWD™ network—an AI-driven, near real-time provider network—designed to deliver anonymized, regulatory-grade clinical data and advanced analytics to life sciences, medical device companies, and research institutions. This collaboration aims to accelerate the development of next-generation medical innovations.
Access to quality healthcare data continues to be a major hurdle in tapping into the projected $868 billion AI healthcare market by 2030¹. With this partnership, OneMedNet is strategically positioned to lead the industry by merging its robust provider network with Palantir’s powerful analytics tools—enabling secure, scalable, and recurring revenue streams on a regulatory-compliant platform.
As part of a multi-year agreement, Palantir’s AI Platform—recognized for its ability to unify complex data and deliver real-time insights—will integrate with OneMedNet’s extensive network, which offers access to over 5 billion administrative claims and 131 million clinical exams from more than 1,750 provider sites, covering areas such as oncology, cardiology, and rare diseases.
Palantir’s software will support OneMedNet’s mission to deliver the most up-to-date data to life sciences organizations, helping to reduce costs and accelerate the time-to-market for innovative healthcare solutions.
“We’re honored to power the AI infrastructure behind OneMedNet’s efforts to fast-track transformative healthcare solutions that aim to enhance patient outcomes,” said Drew Goldstein, Co-Head of Healthcare at Palantir.
Aaron Green, President and CEO of OneMedNet, stated, “Palantir’s AIP is transforming our ability to deliver high-quality, regulatory-compliant data with exceptional speed. This enables us to drive innovation in clinical research and accelerate AI-powered healthcare advancements.”
The Role of Palantir’s Artificial Intelligence Platform
- Faster Data Discovery: Customer data requests are now fulfilled in minutes rather than days, significantly enhancing OneMedNet’s responsiveness and competitive edge.
- Accurate Data Delivery: Clients can create tailored cohorts, ensuring each data point is precisely aligned with their specific research needs and remains fully relevant.
- Conversational Search: A new AI-powered interface—driven by Palantir’s AIP and large language models—enables users to intuitively search, refine, and pinpoint data across massive datasets.
- Increased Productivity: Intelligent automation streamlines operations, boosts efficiency, reduces costs, and supports scalable growth with improved profit margins.
- Healthcare Standards Integration: Palantir’s ontology, integrated with SNOMED, HCPCS, ICD-10, and CPT codes, ensures seamless and interoperable data access for life sciences organizations.
- Anonymization: OneMedNet’s proprietary AI algorithms, running at scale on Palantir’s platform, securely de-identify clinical data to maintain regulatory compliance and safeguard Protected Health Information (PHI).
OneMedNet’s Key Initiatives
- Global Market Expansion: OneMedNet is actively growing its global presence, independently extending its reach to deliver greater value and service to its expanding customer base.
- Advanced Data Cohorts: By integrating OneMedNet’s multimodal, regulatory-grade data with Palantir’s AI platform, the company is enabling the creation of precise, fit-for-purpose data cohorts for use in diagnostics, therapeutics, and personalized medicine.
- Accelerated Clinical Research: Supporting faster and more cost-effective clinical trials through access to rich, longitudinal, and multimodal real-world data.
- Scalable and Compliant Analytics: Delivering a secure, AI-powered analytics platform that combines OneMedNet’s federated provider network with Palantir’s advanced data capabilities to generate tailored, regulatory-compliant datasets.
About Palantir Technologies
Industry-leading software. Learn more at https://www.palantir.com.
About OneMedNet Corporation
OneMedNet is transforming the way Real-World Data (RWD) is accessed and utilized, leveraging the untapped resources of over 1,750 healthcare sites through its innovative iRWD™ platform. This platform goes beyond traditional multi-modal data—providing critical, de-identified medical imaging and electronic health records that drive innovation for pharmaceutical companies, medical device innovators, and AI developers. Covering areas such as rare diseases, oncology, cardiology, and more, OneMedNet delivers precise insights that are reshaping patient care and fueling the next generation of healthcare advancements.
Outside of healthcare, OneMedNet’s proprietary AI technology anonymizes data for sectors like finance, retail, and telecommunications—opening up vast opportunities to rigorously test system upgrades, mitigate risks in complex projects, and securely share sensitive information by removing personal identifiers. Discover more at www.onemednet.com
Future-Oriented Statements
This press release includes forward-looking statements as defined under Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Except for statements of historical fact, all other statements in this release are forward-looking. These may include, but are not limited to, expectations about the benefits of the software platform and the partnership between Palantir and OneMedNet. Forward-looking statements involve inherent risks and uncertainties, many of which are unpredictable or beyond our control. They are based on information available at the time they were made and reflect current expectations, beliefs, and assumptions of management regarding future events. Additional risks, uncertainties, and related information can be found in the filings each company submits to the Securities and Exchange Commission from time to time. Unless required by law, neither company assumes any obligation to update or revise these forward-looking statements publicly, whether due to new information, future events, or otherwise.
Media Contacts
Palantir Technologies
Lisa Gordon
media@palantir.com
OneMedNet Contacts:
Michael Wong, VP Marketing
Email: michael.wong@onemednet.com
